Literature DB >> 21681411

The power and richness of modelling tauopathies in Drosophila.

Katerina Papanikolopoulou1, Efthimios M C Skoulakis.   

Abstract

Tauopathies are a group of neurodegenerative disorders characterised by altered levels of phosphorylation or mutations in the neuronal microtubule protein Tau. The heterogeneous pathology of tauopathies suggests differential susceptibility of different neuronal types to wild-type and mutant Tau. The genetic power and facility of the Drosophila model has been instrumental in exploring the molecular aetiologies of tauopathies, identifying additional proteins likely contributing to neuronal dysfunction and toxicity and novel Tau phosphorylations mediating them. Importantly, recent results indicate tissue- and temporal-specific effects on dysfunction and toxicity coupled with differential effects of distinct Tau isoforms within them. Therefore, they reveal an unexpected richness of the Drosophila model that, coupled with its molecular genetic power, will likely play a significant role in our understanding of multiple tauopathies potentially leading to their differential treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21681411     DOI: 10.1007/s12035-011-8193-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  123 in total

1.  Genetic modifiers of tauopathy in Drosophila.

Authors:  Joshua M Shulman; Mel B Feany
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

Review 2.  GAL4 system in Drosophila: a fly geneticist's Swiss army knife.

Authors:  Joseph B Duffy
Journal:  Genesis       Date:  2002 Sep-Oct       Impact factor: 2.487

Review 3.  Tau protein as a differential biomarker of tauopathies.

Authors:  Nicolas Sergeant; André Delacourte; Luc Buée
Journal:  Biochim Biophys Acta       Date:  2005-01-03

4.  Activation of protein phosphatase 2B and hyperphosphorylation of Tau in Alzheimer's disease.

Authors:  Wei Qian; Xiaomin Yin; Wen Hu; Jianhua Shi; Jianlan Gu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 5.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

6.  Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease.

Authors:  Oyinkan Sofola; Fiona Kerr; Iain Rogers; Richard Killick; Hrvoje Augustin; Carina Gandy; Marcus J Allen; John Hardy; Simon Lovestone; Linda Partridge
Journal:  PLoS Genet       Date:  2010-09-02       Impact factor: 5.917

7.  Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.

Authors:  Y P Wang; J Biernat; M Pickhardt; E Mandelkow; E-M Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

8.  Differential effects of Tau on the integrity and function of neurons essential for learning in Drosophila.

Authors:  Stylianos Kosmidis; Sofia Grammenoudi; Katerina Papanikolopoulou; Efthimios M C Skoulakis
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

Review 9.  Role of tau protein in both physiological and pathological conditions.

Authors:  Jesus Avila; Jose J Lucas; Mar Perez; Felix Hernandez
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

10.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

View more
  9 in total

1.  The C-terminus of tau protein plays an important role in its stability and toxicity.

Authors:  Junhua Geng; Lu Xia; Wanjie Li; Fei Dou
Journal:  J Mol Neurosci       Date:  2014-05-02       Impact factor: 3.444

2.  Drosophila Tau Negatively Regulates Translation and Olfactory Long-Term Memory, But Facilitates Footshock Habituation and Cytoskeletal Homeostasis.

Authors:  Katerina Papanikolopoulou; Ilianna G Roussou; Jean Y Gouzi; Martina Samiotaki; George Panayotou; Luca Turin; Efthimios M C Skoulakis
Journal:  J Neurosci       Date:  2019-09-05       Impact factor: 6.167

3.  The Two Cysteines of Tau Protein Are Functionally Distinct and Contribute Differentially to Its Pathogenicity in Vivo.

Authors:  Engie Prifti; Eleni N Tsakiri; Ergina Vourkou; George Stamatakis; Martina Samiotaki; Katerina Papanikolopoulou
Journal:  J Neurosci       Date:  2020-12-17       Impact factor: 6.167

4.  Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau.

Authors:  Ismael Santa-Maria; Maria E Alaniz; Neil Renwick; Carolina Cela; Tudor A Fulga; David Van Vactor; Thomas Tuschl; Lorraine N Clark; Michael L Shelanski; Brian D McCabe; John F Crary
Journal:  J Clin Invest       Date:  2015-01-09       Impact factor: 14.808

5.  Modelling tauopathies in Drosophila: insights from the fruit fly.

Authors:  Catherine M Cowan; Megan A Sealey; Shmma Quraishe; Marie-Therese Targett; Kristen Marcellus; Douglas Allan; Amritpal Mudher
Journal:  Int J Alzheimers Dis       Date:  2011-12-29

6.  Drosophila models of tauopathies: what have we learned?

Authors:  Marc Gistelinck; Jean-Charles Lambert; Patrick Callaerts; Bart Dermaut; Pierre Dourlen
Journal:  Int J Alzheimers Dis       Date:  2012-06-04

Review 7.  Drosophila Models of Sporadic Parkinson's Disease.

Authors:  Emi Nagoshi
Journal:  Int J Mol Sci       Date:  2018-10-26       Impact factor: 5.923

8.  A Drosophila model of neuronal ceroid lipofuscinosis CLN4 reveals a hypermorphic gain of function mechanism.

Authors:  Elliot Imler; Jin Sang Pyon; Selina Kindelay; Meaghan Torvund; Yong-Quan Zhang; Sreeganga S Chandra; Konrad E Zinsmaier
Journal:  Elife       Date:  2019-10-30       Impact factor: 8.140

9.  DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity.

Authors:  Bangfu Zhu; Tom Parsons; Christopher Foley; Yeng Shaw; Travis Dunckley; Christopher Hulme; James J L Hodge
Journal:  Sci Rep       Date:  2022-09-23       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.